Riskpilot← Back to searchSign inGet full accessNovaria AB
ABActiveOrg 5592704018Ekliden 11 BGeneral medical practice activities · NACE 8621Est. 20201 employees
Revenue 2025
SEK 8K
EBITDA margin
-1461.8%
+31% vs 2024
Equity ratio
38.4%
Financial strength
Net profit 2025
SEK -124K
+25% vs 2024
| Revenue | SEK 8K | — |
| EBITDA | SEK -122K | +31% |
| Net profit | SEK -124K | +25% |
| Total assets | SEK 41K | -69% |
| Equity | SEK 16K | -84% |
| Employees | 1 | — |
Legal name
Novaria AB
Org number
5592704018
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 september 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk konsult. Läkartjänster.
Address
Ekliden 11 B
Email
ibrahim.gergi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 688 | 92 | 216 | 0 | 8 |
| Staff expenses | — | −19 | −22 | −20 | −20 |
| EBITDA | 349 | −77 | 50 | −176 | −122 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 349 | −77 | 50 | −176 | −122 |
| Net financials | −1 | −1 | −0 | −0 | −2 |
| Profit before tax | 259 | 11 | 38 | −164 | −124 |
| Tax | −58 | −4 | −8 | — | — |
| Net profit | 201 | 7 | 30 | −164 | −124 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 342 | 268 | 314 | 132 | 41 |
| Equity | 226 | 234 | 264 | 100 | 16 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 27 | 34 | 39 | 32 | 25 |
| Total debt | 27 | 34 | 39 | 32 | 25 |
EBITDA margin
-1461.8%
This company
15.8%
Market median
-9352% vs market
20212025
Equity ratio
38.4%
This company
38.2%
Market median
+1% vs market
20212025
Return on equity
-780.5%
This company
18.4%
Market median
-4342% vs market
20212025
Net profit margin
-1481.3%
This company
8.1%
Market median
-18388% vs market
20212025
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20212025
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Novaria AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexandra Baho | Deputy Board Member | 0 companies |
| Ivona Kass Gergi | Deputy Board Member | 0 companies |
| Anna Michelle Zetterström | Deputy Board Member | 0 companies |
| Ibrahim Andreas Kass Gergi | Board of Directors | 0 companies |